

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | glycosphingolipid catabolic process (GO:0046479) | 4.29730694 |
| 2 | oligosaccharide catabolic process (GO:0009313) | 4.03748008 |
| 3 | low-density lipoprotein particle clearance (GO:0034383) | 3.96487233 |
| 4 | glycolipid catabolic process (GO:0019377) | 3.85693044 |
| 5 | barbed-end actin filament capping (GO:0051016) | 3.80269791 |
| 6 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.68742368 |
| 7 | protein localization to endosome (GO:0036010) | 3.68645337 |
| 8 | apoptotic cell clearance (GO:0043277) | 3.62052809 |
| 9 | response to lipoprotein particle (GO:0055094) | 3.59476130 |
| 10 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.54616147 |
| 11 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.49794652 |
| 12 | virion attachment to host cell (GO:0019062) | 3.46296290 |
| 13 | adhesion of symbiont to host cell (GO:0044650) | 3.46296290 |
| 14 | alpha-linolenic acid metabolic process (GO:0036109) | 3.45554754 |
| 15 | ceramide catabolic process (GO:0046514) | 3.28646425 |
| 16 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.28250745 |
| 17 | L-phenylalanine catabolic process (GO:0006559) | 3.28250745 |
| 18 | regulation of mononuclear cell migration (GO:0071675) | 3.20945205 |
| 19 | response to thyroid hormone (GO:0097066) | 3.18573960 |
| 20 | adhesion of symbiont to host (GO:0044406) | 3.13589828 |
| 21 | pinocytosis (GO:0006907) | 3.12593734 |
| 22 | L-phenylalanine metabolic process (GO:0006558) | 3.11532789 |
| 23 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.11532789 |
| 24 | plasma lipoprotein particle clearance (GO:0034381) | 3.09908248 |
| 25 | axon ensheathment in central nervous system (GO:0032291) | 3.09470687 |
| 26 | central nervous system myelination (GO:0022010) | 3.09470687 |
| 27 | response to peptidoglycan (GO:0032494) | 3.08884818 |
| 28 | cell adhesion mediated by integrin (GO:0033627) | 3.06392434 |
| 29 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.03211457 |
| 30 | myelin maintenance (GO:0043217) | 3.02821289 |
| 31 | hyaluronan catabolic process (GO:0030214) | 3.01363691 |
| 32 | amino sugar catabolic process (GO:0046348) | 3.00412940 |
| 33 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.99994459 |
| 34 | positive regulation of extracellular matrix organization (GO:1903055) | 2.98182500 |
| 35 | regulation of cholesterol storage (GO:0010885) | 2.98131771 |
| 36 | creatine metabolic process (GO:0006600) | 2.96563625 |
| 37 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.95565426 |
| 38 | positive regulation by symbiont of host defense response (GO:0052509) | 2.92481890 |
| 39 | modulation by symbiont of host defense response (GO:0052031) | 2.92481890 |
| 40 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.92481890 |
| 41 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.92481890 |
| 42 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.92481890 |
| 43 | modulation by symbiont of host immune response (GO:0052553) | 2.92481890 |
| 44 | membrane lipid catabolic process (GO:0046466) | 2.92443704 |
| 45 | hemidesmosome assembly (GO:0031581) | 2.89461762 |
| 46 | endodermal cell differentiation (GO:0035987) | 2.88799747 |
| 47 | negative regulation of interleukin-12 production (GO:0032695) | 2.88759106 |
| 48 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.86676749 |
| 49 | cysteine metabolic process (GO:0006534) | 2.85168837 |
| 50 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.84874495 |
| 51 | sphingolipid catabolic process (GO:0030149) | 2.83101562 |
| 52 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.81883591 |
| 53 | protein carboxylation (GO:0018214) | 2.81883591 |
| 54 | macroautophagy (GO:0016236) | 2.79990845 |
| 55 | fatty acid elongation (GO:0030497) | 2.78568251 |
| 56 | mannose metabolic process (GO:0006013) | 2.77082245 |
| 57 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.77016390 |
| 58 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.73826812 |
| 59 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.73730929 |
| 60 | COPI coating of Golgi vesicle (GO:0048205) | 2.73401811 |
| 61 | Golgi transport vesicle coating (GO:0048200) | 2.73401811 |
| 62 | regulation of cholesterol homeostasis (GO:2000188) | 2.69672036 |
| 63 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.68962292 |
| 64 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.67798071 |
| 65 | amyloid precursor protein catabolic process (GO:0042987) | 2.67388967 |
| 66 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.66865553 |
| 67 | regulation of macrophage chemotaxis (GO:0010758) | 2.63323541 |
| 68 | decidualization (GO:0046697) | 2.63083576 |
| 69 | glial cell migration (GO:0008347) | 2.62974728 |
| 70 | sulfur amino acid catabolic process (GO:0000098) | 2.62889119 |
| 71 | positive regulation of cholesterol efflux (GO:0010875) | 2.62198553 |
| 72 | import into cell (GO:0098657) | 2.60967984 |
| 73 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.60771071 |
| 74 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.59690664 |
| 75 | positive regulation of p38MAPK cascade (GO:1900745) | 2.58909300 |
| 76 | response to methylmercury (GO:0051597) | 2.58827136 |
| 77 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.57885044 |
| 78 | detection of molecule of bacterial origin (GO:0032490) | 2.57140435 |
| 79 | 4-hydroxyproline metabolic process (GO:0019471) | 2.55411771 |
| 80 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.55173345 |
| 81 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.55040077 |
| 82 | response to mercury ion (GO:0046689) | 2.53181552 |
| 83 | glycosylceramide metabolic process (GO:0006677) | 2.52918769 |
| 84 | regulation of lipoprotein metabolic process (GO:0050746) | 2.52416590 |
| 85 | protein retention in ER lumen (GO:0006621) | 2.52022637 |
| 86 | keratan sulfate catabolic process (GO:0042340) | 2.51779148 |
| 87 | regulation of extracellular matrix disassembly (GO:0010715) | 2.50521184 |
| 88 | peptide catabolic process (GO:0043171) | 2.50294031 |
| 89 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.50193248 |
| 90 | positive regulation of receptor recycling (GO:0001921) | 2.49803173 |
| 91 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.49297494 |
| 92 | regulation of early endosome to late endosome transport (GO:2000641) | 2.48986764 |
| 93 | surfactant homeostasis (GO:0043129) | 2.47934777 |
| 94 | epithelial cell-cell adhesion (GO:0090136) | 2.46961952 |
| 95 | amyloid precursor protein metabolic process (GO:0042982) | 2.46908288 |
| 96 | very long-chain fatty acid metabolic process (GO:0000038) | 2.46704456 |
| 97 | acyl-CoA biosynthetic process (GO:0071616) | 2.46147102 |
| 98 | thioester biosynthetic process (GO:0035384) | 2.46147102 |
| 99 | substrate-dependent cell migration (GO:0006929) | 2.44323577 |
| 100 | glyoxylate metabolic process (GO:0046487) | 2.43963250 |
| 101 | cellular response to vitamin (GO:0071295) | 2.43659874 |
| 102 | regulation of vitamin metabolic process (GO:0030656) | 2.43462047 |
| 103 | axon ensheathment (GO:0008366) | 2.43298256 |
| 104 | ensheathment of neurons (GO:0007272) | 2.43298256 |
| 105 | cortical actin cytoskeleton organization (GO:0030866) | 2.43238156 |
| 106 | cell-substrate junction assembly (GO:0007044) | 2.40990740 |
| 107 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.40618810 |
| 108 | basement membrane organization (GO:0071711) | 2.40215201 |
| 109 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.40190130 |
| 110 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.40058143 |
| 111 | regulation of podosome assembly (GO:0071801) | 2.39845250 |
| 112 | lysine metabolic process (GO:0006553) | 2.39723790 |
| 113 | lysine catabolic process (GO:0006554) | 2.39723790 |
| 114 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.38841314 |
| 115 | collagen metabolic process (GO:0032963) | 2.38804369 |
| 116 | membrane protein ectodomain proteolysis (GO:0006509) | 2.38534100 |
| 117 | cellular modified amino acid catabolic process (GO:0042219) | 2.37569292 |
| 118 | regulation of monocyte chemotaxis (GO:0090025) | 2.37183973 |
| 119 | collagen catabolic process (GO:0030574) | 2.36941685 |
| 120 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.36854574 |
| 121 | NADPH regeneration (GO:0006740) | 2.35960827 |
| 122 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.35471738 |
| 123 | response to laminar fluid shear stress (GO:0034616) | 2.35187812 |
| 124 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.34175772 |
| 125 | myelination (GO:0042552) | 2.34116001 |
| 126 | aspartate family amino acid catabolic process (GO:0009068) | 2.33788003 |
| 127 | positive regulation of osteoblast proliferation (GO:0033690) | 2.32949647 |
| 128 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.31136031 |
| 129 | pentose-phosphate shunt (GO:0006098) | 2.30629414 |
| 130 | skin morphogenesis (GO:0043589) | 2.30001428 |
| 131 | myeloid dendritic cell differentiation (GO:0043011) | 2.29404212 |
| 132 | hypotonic response (GO:0006971) | 2.29112515 |
| 133 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.28653892 |
| 134 | N-acetylneuraminate metabolic process (GO:0006054) | 2.28549272 |
| 135 | regulation of cholesterol metabolic process (GO:0090181) | 2.28244970 |
| 136 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.28180290 |
| 137 | regulation of extracellular matrix organization (GO:1903053) | 2.27868685 |
| 138 | drug transmembrane transport (GO:0006855) | 2.27741603 |
| 139 | stress fiber assembly (GO:0043149) | 2.27013494 |
| 140 | growth hormone receptor signaling pathway (GO:0060396) | 2.25836428 |
| 141 | extracellular matrix disassembly (GO:0022617) | 2.25223018 |
| 142 | endocytic recycling (GO:0032456) | 2.25172604 |
| 143 | acetyl-CoA metabolic process (GO:0006084) | 2.24521581 |
| 144 | fatty acid beta-oxidation (GO:0006635) | 2.23755617 |
| 145 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.22262702 |
| 146 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.22165369 |
| 147 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.21896005 |
| 148 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.20645858 |
| 149 | macrophage activation involved in immune response (GO:0002281) | 2.20321154 |
| 150 | protein-lipid complex assembly (GO:0065005) | 2.20203533 |
| 151 | NIK/NF-kappaB signaling (GO:0038061) | 2.20175137 |
| 152 | multicellular organismal catabolic process (GO:0044243) | 2.20011098 |
| 153 | T-helper 1 type immune response (GO:0042088) | 2.18742541 |
| 154 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.18723788 |
| 155 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.18251546 |
| 156 | embryo implantation (GO:0007566) | 2.18236205 |
| 157 | response to muramyl dipeptide (GO:0032495) | 2.18229878 |
| 158 | semaphorin-plexin signaling pathway (GO:0071526) | 2.17828477 |
| 159 | cholesterol metabolic process (GO:0008203) | 2.17192951 |
| 160 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.17046746 |
| 161 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.16743398 |
| 162 | complement activation, alternative pathway (GO:0006957) | 2.16528166 |
| 163 | positive regulation of cholesterol transport (GO:0032376) | 2.16485487 |
| 164 | positive regulation of sterol transport (GO:0032373) | 2.16485487 |
| 165 | fatty acid oxidation (GO:0019395) | 2.16229999 |
| 166 | lipid oxidation (GO:0034440) | 2.15833688 |
| 167 | heme transport (GO:0015886) | 2.15766320 |
| 168 | cellular copper ion homeostasis (GO:0006878) | 2.15716104 |
| 169 | cortical cytoskeleton organization (GO:0030865) | 2.15496062 |
| 170 | ethanol oxidation (GO:0006069) | 2.15215888 |
| 171 | positive regulation of phagocytosis (GO:0050766) | 2.14783392 |
| 172 | modulation by symbiont of host cellular process (GO:0044068) | 2.14297912 |
| 173 | response to progesterone (GO:0032570) | 2.13948700 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.50382940 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.45600217 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.42981282 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.12112653 |
| 5 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.06115252 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.00235655 |
| 7 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.80978699 |
| 8 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.78755934 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.50238359 |
| 10 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.26379290 |
| 11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.17115001 |
| 12 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.16032214 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.07161316 |
| 14 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.07062030 |
| 15 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.03904140 |
| 16 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.02455917 |
| 17 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.95771528 |
| 18 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.95695330 |
| 19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.89004971 |
| 20 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.88549202 |
| 21 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.86674541 |
| 22 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.86236150 |
| 23 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.77465868 |
| 24 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.74828194 |
| 25 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.73906101 |
| 26 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.69717719 |
| 27 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.69020271 |
| 28 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.68748139 |
| 29 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.67850169 |
| 30 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.65694852 |
| 31 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.65316727 |
| 32 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.64887537 |
| 33 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.63280559 |
| 34 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.61936245 |
| 35 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.61936245 |
| 36 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.60100744 |
| 37 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.57780860 |
| 38 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.56091407 |
| 39 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.55564613 |
| 40 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.53294690 |
| 41 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.51844480 |
| 42 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.51677739 |
| 43 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.48507944 |
| 44 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.47185403 |
| 45 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.40515831 |
| 46 | GATA1_19941826_ChIP-Seq_K562_Human | 1.38997852 |
| 47 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.37882118 |
| 48 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.37858298 |
| 49 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.36506907 |
| 50 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.35297823 |
| 51 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.34802459 |
| 52 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.33481333 |
| 53 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.32644585 |
| 54 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.31226118 |
| 55 | CJUN_26792858_Chip-Seq_BT549_Human | 1.30941060 |
| 56 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.28943541 |
| 57 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.28255551 |
| 58 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.27463924 |
| 59 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.27435173 |
| 60 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.27253947 |
| 61 | MYC_22102868_ChIP-Seq_BL_Human | 1.25210277 |
| 62 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.22653114 |
| 63 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21288278 |
| 64 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.20428167 |
| 65 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.20428167 |
| 66 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.20268959 |
| 67 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.19079837 |
| 68 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.17932457 |
| 69 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17576326 |
| 70 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.16791709 |
| 71 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.16621561 |
| 72 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.15616680 |
| 73 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15154360 |
| 74 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14467455 |
| 75 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.13910550 |
| 76 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.12303207 |
| 77 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.12280065 |
| 78 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.12270119 |
| 79 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.12257318 |
| 80 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.11934848 |
| 81 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.11708565 |
| 82 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.11335921 |
| 83 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.10916214 |
| 84 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.10876970 |
| 85 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.10713843 |
| 86 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.09564421 |
| 87 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09094000 |
| 88 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.09061974 |
| 89 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.07923646 |
| 90 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07076168 |
| 91 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.06485890 |
| 92 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.05899528 |
| 93 | ATF3_27146783_Chip-Seq_COLON_Human | 1.05421833 |
| 94 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.05388011 |
| 95 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.05337692 |
| 96 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.04623432 |
| 97 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.04467077 |
| 98 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.04148057 |
| 99 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.04099634 |
| 100 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03667365 |
| 101 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.03472285 |
| 102 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.03469732 |
| 103 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.03119504 |
| 104 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.02376189 |
| 105 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.01630607 |
| 106 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.01468602 |
| 107 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.01344662 |
| 108 | MAF_26560356_Chip-Seq_TH1_Human | 1.00302167 |
| 109 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.00128381 |
| 110 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.99623643 |
| 111 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.98496691 |
| 112 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.96898593 |
| 113 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.96497339 |
| 114 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.96286201 |
| 115 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.96220778 |
| 116 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.96071227 |
| 117 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.94558223 |
| 118 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.94489510 |
| 119 | GATA2_19941826_ChIP-Seq_K562_Human | 0.94394848 |
| 120 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.92616290 |
| 121 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.92509011 |
| 122 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.91107348 |
| 123 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.90951489 |
| 124 | GATA1_22025678_ChIP-Seq_K562_Human | 0.90460008 |
| 125 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.89804080 |
| 126 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.89237168 |
| 127 | KDM2B_26808549_Chip-Seq_K562_Human | 0.88914068 |
| 128 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.88787720 |
| 129 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.88182860 |
| 130 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.86843310 |
| 131 | SPI1_23127762_ChIP-Seq_K562_Human | 0.86483178 |
| 132 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.85046694 |
| 133 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.84595548 |
| 134 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.84595548 |
| 135 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.84263848 |
| 136 | * TFEB_21752829_ChIP-Seq_HELA_Human | 0.83002654 |
| 137 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.81756203 |
| 138 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.81062852 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 4.23691539 |
| 2 | * MP0005058_abnormal_lysosome_morphology | 4.04007461 |
| 3 | MP0009840_abnormal_foam_cell | 3.76401049 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 3.06992507 |
| 5 | MP0005360_urolithiasis | 2.76934552 |
| 6 | MP0003195_calcinosis | 2.68145271 |
| 7 | MP0002139_abnormal_hepatobiliary_system | 2.66880150 |
| 8 | MP0003690_abnormal_glial_cell | 2.61770894 |
| 9 | MP0003172_abnormal_lysosome_physiology | 2.56776852 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.36731396 |
| 11 | MP0000604_amyloidosis | 2.35999794 |
| 12 | MP0000920_abnormal_myelination | 2.32412177 |
| 13 | MP0001958_emphysema | 2.29668570 |
| 14 | MP0003300_gastrointestinal_ulcer | 2.11800080 |
| 15 | MP0003329_amyloid_beta_deposits | 1.99159261 |
| 16 | MP0005275_abnormal_skin_tensile | 1.93119513 |
| 17 | MP0004510_myositis | 1.92004948 |
| 18 | MP0005083_abnormal_biliary_tract | 1.81269935 |
| 19 | MP0003806_abnormal_nucleotide_metabolis | 1.80904751 |
| 20 | MP0003566_abnormal_cell_adhesion | 1.70346158 |
| 21 | MP0004185_abnormal_adipocyte_glucose | 1.70140186 |
| 22 | MP0005365_abnormal_bile_salt | 1.67492008 |
| 23 | MP0005332_abnormal_amino_acid | 1.64240021 |
| 24 | MP0006082_CNS_inflammation | 1.64043111 |
| 25 | MP0008875_abnormal_xenobiotic_pharmacok | 1.62859273 |
| 26 | MP0000858_altered_metastatic_potential | 1.61829947 |
| 27 | MP0002148_abnormal_hypersensitivity_rea | 1.60765581 |
| 28 | MP0004272_abnormal_basement_membrane | 1.57018305 |
| 29 | MP0003303_peritoneal_inflammation | 1.56790349 |
| 30 | MP0004043_abnormal_pH_regulation | 1.54947928 |
| 31 | MP0003252_abnormal_bile_duct | 1.53848679 |
| 32 | MP0002295_abnormal_pulmonary_circulatio | 1.51437302 |
| 33 | MP0005623_abnormal_meninges_morphology | 1.50712799 |
| 34 | MP0003724_increased_susceptibility_to | 1.50189704 |
| 35 | MP0009643_abnormal_urine_homeostasis | 1.48866138 |
| 36 | MP0003634_abnormal_glial_cell | 1.48107980 |
| 37 | MP0005257_abnormal_intraocular_pressure | 1.46254322 |
| 38 | MP0010329_abnormal_lipoprotein_level | 1.42065556 |
| 39 | MP0002118_abnormal_lipid_homeostasis | 1.39571938 |
| 40 | MP0003950_abnormal_plasma_membrane | 1.37828508 |
| 41 | MP0002877_abnormal_melanocyte_morpholog | 1.37534020 |
| 42 | MP0004130_abnormal_muscle_cell | 1.37530802 |
| 43 | MP0008260_abnormal_autophagy | 1.33789581 |
| 44 | MP0009785_altered_susceptibility_to | 1.32623787 |
| 45 | MP0005085_abnormal_gallbladder_physiolo | 1.31958365 |
| 46 | MP0003075_altered_response_to | 1.26286191 |
| 47 | MP0005025_abnormal_response_to | 1.26214169 |
| 48 | MP0009384_cardiac_valve_regurgitation | 1.25097510 |
| 49 | MP0001542_abnormal_bone_strength | 1.24418527 |
| 50 | MP0000747_muscle_weakness | 1.24075402 |
| 51 | MP0005076_abnormal_cell_differentiation | 1.21982846 |
| 52 | MP0005000_abnormal_immune_tolerance | 1.20906144 |
| 53 | MP0003091_abnormal_cell_migration | 1.20158324 |
| 54 | MP0003828_pulmonary_edema | 1.19363814 |
| 55 | MP0003279_aneurysm | 1.17100423 |
| 56 | MP0001756_abnormal_urination | 1.17087558 |
| 57 | MP0004858_abnormal_nervous_system | 1.16969573 |
| 58 | MP0005464_abnormal_platelet_physiology | 1.16219603 |
| 59 | MP0000685_abnormal_immune_system | 1.16125884 |
| 60 | MP0000767_abnormal_smooth_muscle | 1.15360149 |
| 61 | MP0005409_darkened_coat_color | 1.15103960 |
| 62 | MP0001790_abnormal_immune_system | 1.14484151 |
| 63 | MP0005387_immune_system_phenotype | 1.14484151 |
| 64 | MP0001533_abnormal_skeleton_physiology | 1.13570903 |
| 65 | MP0005666_abnormal_adipose_tissue | 1.13539339 |
| 66 | MP0002090_abnormal_vision | 1.13151275 |
| 67 | MP0001853_heart_inflammation | 1.12773626 |
| 68 | MP0004019_abnormal_vitamin_homeostasis | 1.12751498 |
| 69 | MP0001666_abnormal_nutrient_absorption | 1.11491527 |
| 70 | MP0009278_abnormal_bone_marrow | 1.10360465 |
| 71 | MP0001835_abnormal_antigen_presentation | 1.10299672 |
| 72 | MP0000609_abnormal_liver_physiology | 1.08565269 |
| 73 | MP0002168_other_aberrant_phenotype | 1.08552731 |
| 74 | MP0010234_abnormal_vibrissa_follicle | 1.08523362 |
| 75 | MP0002896_abnormal_bone_mineralization | 1.07868539 |
| 76 | MP0002796_impaired_skin_barrier | 1.07798494 |
| 77 | MP0005375_adipose_tissue_phenotype | 1.06436842 |
| 78 | MP0005167_abnormal_blood-brain_barrier | 1.04039131 |
| 79 | MP0005390_skeleton_phenotype | 1.03093616 |
| 80 | MP0000733_abnormal_muscle_development | 1.02625085 |
| 81 | MP0002998_abnormal_bone_remodeling | 1.00222334 |
| 82 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.99717560 |
| 83 | MP0002254_reproductive_system_inflammat | 0.99082258 |
| 84 | MP0009764_decreased_sensitivity_to | 0.98169707 |
| 85 | MP0002138_abnormal_hepatobiliary_system | 0.97424036 |
| 86 | MP0008004_abnormal_stomach_pH | 0.97042791 |
| 87 | MP0000013_abnormal_adipose_tissue | 0.96984358 |
| 88 | MP0000003_abnormal_adipose_tissue | 0.96275020 |
| 89 | MP0005023_abnormal_wound_healing | 0.96010335 |
| 90 | MP0003453_abnormal_keratinocyte_physiol | 0.95165140 |
| 91 | MP0010155_abnormal_intestine_physiology | 0.95078124 |
| 92 | MP0003656_abnormal_erythrocyte_physiolo | 0.95055045 |
| 93 | MP0002452_abnormal_antigen_presenting | 0.94418947 |
| 94 | MP0003186_abnormal_redox_activity | 0.94322446 |
| 95 | MP0003436_decreased_susceptibility_to | 0.94081381 |
| 96 | MP0001849_ear_inflammation | 0.94029113 |
| 97 | MP0009780_abnormal_chondrocyte_physiolo | 0.93884217 |
| 98 | MP0010678_abnormal_skin_adnexa | 0.92749718 |
| 99 | MP0001845_abnormal_inflammatory_respons | 0.91270913 |
| 100 | MP0002136_abnormal_kidney_physiology | 0.91165126 |
| 101 | MP0003283_abnormal_digestive_organ | 0.90892685 |
| 102 | MP0001216_abnormal_epidermal_layer | 0.90370030 |
| 103 | MP0001915_intracranial_hemorrhage | 0.89379552 |
| 104 | MP0001299_abnormal_eye_distance/ | 0.89302652 |
| 105 | MP0005595_abnormal_vascular_smooth | 0.89122147 |
| 106 | MP0001243_abnormal_dermal_layer | 0.89110919 |
| 107 | MP0003045_fibrosis | 0.88709046 |
| 108 | MP0006054_spinal_hemorrhage | 0.88532532 |
| 109 | MP0000343_altered_response_to | 0.87522768 |
| 110 | MP0005319_abnormal_enzyme/_coenzyme | 0.86518366 |
| 111 | MP0004947_skin_inflammation | 0.85906055 |
| 112 | MP0004883_abnormal_blood_vessel | 0.84607514 |
| 113 | MP0002405_respiratory_system_inflammati | 0.82591156 |
| 114 | MP0002419_abnormal_innate_immunity | 0.82483472 |
| 115 | MP0004885_abnormal_endolymph | 0.82238803 |
| 116 | MP0005164_abnormal_response_to | 0.81451518 |
| 117 | MP0005670_abnormal_white_adipose | 0.80713480 |
| 118 | MP0005310_abnormal_salivary_gland | 0.79127511 |
| 119 | MP0002723_abnormal_immune_serum | 0.78573938 |
| 120 | MP0001851_eye_inflammation | 0.78571600 |
| 121 | MP0001765_abnormal_ion_homeostasis | 0.77412054 |
| 122 | MP0003632_abnormal_nervous_system | 0.77061889 |
| 123 | MP0005503_abnormal_tendon_morphology | 0.77024854 |
| 124 | MP0010368_abnormal_lymphatic_system | 0.76100440 |
| 125 | MP0004233_abnormal_muscle_weight | 0.76033510 |
| 126 | MP0002971_abnormal_brown_adipose | 0.75703463 |
| 127 | MP0000249_abnormal_blood_vessel | 0.75133649 |
| 128 | MP0005451_abnormal_body_composition | 0.74746542 |
| 129 | MP0005508_abnormal_skeleton_morphology | 0.73263999 |
| 130 | MP0005165_increased_susceptibility_to | 0.72966322 |
| 131 | MP0001661_extended_life_span | 0.72914189 |
| 132 | MP0002060_abnormal_skin_morphology | 0.72818093 |
| 133 | MP0003448_altered_tumor_morphology | 0.72341468 |
| 134 | MP0001545_abnormal_hematopoietic_system | 0.70742279 |
| 135 | MP0005397_hematopoietic_system_phenotyp | 0.70742279 |
| 136 | MP0009333_abnormal_splenocyte_physiolog | 0.69869499 |
| 137 | MP0000598_abnormal_liver_morphology | 0.67288492 |
| 138 | MP0008469_abnormal_protein_level | 0.66804949 |
| 139 | MP0003795_abnormal_bone_structure | 0.65636941 |
| 140 | MP0010352_gastrointestinal_tract_polyps | 0.65572063 |
| 141 | MP0005166_decreased_susceptibility_to | 0.65154670 |
| 142 | MP0002933_joint_inflammation | 0.64257304 |
| 143 | MP0003183_abnormal_peptide_metabolism | 0.62578552 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased cerebral lipofuscin (HP:0011813) | 4.78241265 |
| 2 | Dysostosis multiplex (HP:0000943) | 4.47104972 |
| 3 | Neurofibrillary tangles (HP:0002185) | 4.44977328 |
| 4 | Vacuolated lymphocytes (HP:0001922) | 4.20791043 |
| 5 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.97670314 |
| 6 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.79915314 |
| 7 | Mucopolysacchariduria (HP:0008155) | 3.79915314 |
| 8 | Axonal loss (HP:0003447) | 3.75206403 |
| 9 | Cerebral inclusion bodies (HP:0100314) | 3.73620550 |
| 10 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.54361757 |
| 11 | Premature rupture of membranes (HP:0001788) | 3.53456739 |
| 12 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.52209459 |
| 13 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.52209459 |
| 14 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.52209459 |
| 15 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.33286778 |
| 16 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.33286778 |
| 17 | Abnormality of glycolipid metabolism (HP:0010969) | 3.33286778 |
| 18 | Xanthomatosis (HP:0000991) | 3.30160295 |
| 19 | Systemic lupus erythematosus (HP:0002725) | 3.11319995 |
| 20 | Loss of speech (HP:0002371) | 3.00729201 |
| 21 | Nuclear cataract (HP:0100018) | 2.90584546 |
| 22 | Supranuclear gaze palsy (HP:0000605) | 2.66315925 |
| 23 | Complement deficiency (HP:0004431) | 2.64997504 |
| 24 | Eczematoid dermatitis (HP:0000976) | 2.63009500 |
| 25 | Myocardial infarction (HP:0001658) | 2.59953294 |
| 26 | Deep venous thrombosis (HP:0002625) | 2.59725289 |
| 27 | Atrophic scars (HP:0001075) | 2.58523812 |
| 28 | Cerebral aneurysm (HP:0004944) | 2.53243088 |
| 29 | Protrusio acetabuli (HP:0003179) | 2.51849188 |
| 30 | Peripheral demyelination (HP:0011096) | 2.48270704 |
| 31 | Global brain atrophy (HP:0002283) | 2.40781167 |
| 32 | Asymmetric septal hypertrophy (HP:0001670) | 2.39531442 |
| 33 | Turricephaly (HP:0000262) | 2.39490801 |
| 34 | Cervical subluxation (HP:0003308) | 2.39365988 |
| 35 | Abnormality of macrophages (HP:0004311) | 2.39312964 |
| 36 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.38971849 |
| 37 | Peritonitis (HP:0002586) | 2.34928745 |
| 38 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.31954426 |
| 39 | Osteolytic defects of the hand bones (HP:0009699) | 2.31954426 |
| 40 | Protuberant abdomen (HP:0001538) | 2.29515669 |
| 41 | Apathy (HP:0000741) | 2.26631027 |
| 42 | Upper limb amyotrophy (HP:0009129) | 2.24962436 |
| 43 | Distal upper limb amyotrophy (HP:0007149) | 2.24962436 |
| 44 | Intrahepatic cholestasis (HP:0001406) | 2.22872691 |
| 45 | Hypokalemic alkalosis (HP:0001949) | 2.21473941 |
| 46 | Hyperlipoproteinemia (HP:0010980) | 2.21231913 |
| 47 | Glomerulonephritis (HP:0000099) | 2.19546991 |
| 48 | Retinal atrophy (HP:0001105) | 2.18706115 |
| 49 | Skin nodule (HP:0200036) | 2.18040022 |
| 50 | Diminished motivation (HP:0000745) | 2.17758312 |
| 51 | Spondylolisthesis (HP:0003302) | 2.17017462 |
| 52 | Neuronal loss in central nervous system (HP:0002529) | 2.16874389 |
| 53 | Increased CSF protein (HP:0002922) | 2.14920006 |
| 54 | Fragile skin (HP:0001030) | 2.13473838 |
| 55 | Hypoglycemic coma (HP:0001325) | 2.12199741 |
| 56 | Shallow orbits (HP:0000586) | 2.09508361 |
| 57 | Abnormality of complement system (HP:0005339) | 2.09270495 |
| 58 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.07245581 |
| 59 | Purpura (HP:0000979) | 2.06152783 |
| 60 | Increased circulating renin level (HP:0000848) | 2.05117234 |
| 61 | Back pain (HP:0003418) | 2.02831246 |
| 62 | Broad metatarsal (HP:0001783) | 2.01191342 |
| 63 | Upper motor neuron abnormality (HP:0002127) | 2.01097323 |
| 64 | Recurrent bacterial skin infections (HP:0005406) | 2.01050541 |
| 65 | Bone pain (HP:0002653) | 2.00734241 |
| 66 | Joint stiffness (HP:0001387) | 2.00091464 |
| 67 | Abnormality of proline metabolism (HP:0010907) | 2.00037773 |
| 68 | Hydroxyprolinuria (HP:0003080) | 2.00037773 |
| 69 | Recurrent abscess formation (HP:0002722) | 1.99719820 |
| 70 | Disinhibition (HP:0000734) | 1.99302054 |
| 71 | Wormian bones (HP:0002645) | 1.99177764 |
| 72 | Ovoid vertebral bodies (HP:0003300) | 1.98724667 |
| 73 | Hyporeflexia of lower limbs (HP:0002600) | 1.98543258 |
| 74 | Abnormality of the Achilles tendon (HP:0005109) | 1.95549868 |
| 75 | Mitral stenosis (HP:0001718) | 1.94837943 |
| 76 | Ketosis (HP:0001946) | 1.93934371 |
| 77 | Bladder diverticulum (HP:0000015) | 1.93086376 |
| 78 | Blue sclerae (HP:0000592) | 1.93085401 |
| 79 | Genu recurvatum (HP:0002816) | 1.92320094 |
| 80 | Dilatation of the ascending aorta (HP:0005111) | 1.92306816 |
| 81 | Ketoacidosis (HP:0001993) | 1.92117834 |
| 82 | Hand muscle atrophy (HP:0009130) | 1.91891860 |
| 83 | J-shaped sella turcica (HP:0002680) | 1.91585410 |
| 84 | Amyloidosis (HP:0011034) | 1.90980568 |
| 85 | Aortic aneurysm (HP:0004942) | 1.86804719 |
| 86 | Aneurysm (HP:0002617) | 1.85756402 |
| 87 | Muscle fiber splitting (HP:0003555) | 1.85329626 |
| 88 | Spinal rigidity (HP:0003306) | 1.85200692 |
| 89 | Achilles tendon contracture (HP:0001771) | 1.84252843 |
| 90 | Vertebral compression fractures (HP:0002953) | 1.83963394 |
| 91 | Natal tooth (HP:0000695) | 1.83778063 |
| 92 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.83741975 |
| 93 | Stridor (HP:0010307) | 1.83413801 |
| 94 | Distal lower limb muscle weakness (HP:0009053) | 1.83299105 |
| 95 | Mutism (HP:0002300) | 1.83282328 |
| 96 | Clumsiness (HP:0002312) | 1.83167210 |
| 97 | Progressive neurologic deterioration (HP:0002344) | 1.83059645 |
| 98 | Hepatosplenomegaly (HP:0001433) | 1.82972417 |
| 99 | Hypoalphalipoproteinemia (HP:0003233) | 1.82731295 |
| 100 | Short nail (HP:0001799) | 1.82586226 |
| 101 | Hyperacusis (HP:0010780) | 1.82442559 |
| 102 | Cardiovascular calcification (HP:0011915) | 1.81952398 |
| 103 | Nephritis (HP:0000123) | 1.81155350 |
| 104 | Ankle contracture (HP:0006466) | 1.80728047 |
| 105 | Interstitial pulmonary disease (HP:0006530) | 1.79498383 |
| 106 | Focal segmental glomerulosclerosis (HP:0000097) | 1.79485159 |
| 107 | Ulnar bowing (HP:0003031) | 1.78990283 |
| 108 | Vascular tortuosity (HP:0004948) | 1.78289481 |
| 109 | Aortic dissection (HP:0002647) | 1.77758211 |
| 110 | Gout (HP:0001997) | 1.76878602 |
| 111 | Abnormality of purine metabolism (HP:0004352) | 1.76165772 |
| 112 | Increased connective tissue (HP:0009025) | 1.75470979 |
| 113 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.75444281 |
| 114 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.75159031 |
| 115 | Arterial tortuosity (HP:0005116) | 1.75147261 |
| 116 | Cardiomegaly (HP:0001640) | 1.74916988 |
| 117 | Sensorimotor neuropathy (HP:0007141) | 1.74649278 |
| 118 | Spastic tetraparesis (HP:0001285) | 1.74274203 |
| 119 | Distal lower limb amyotrophy (HP:0008944) | 1.72468420 |
| 120 | Abnormality of the lumbar spine (HP:0100712) | 1.71781461 |
| 121 | Hyperparathyroidism (HP:0000843) | 1.70706578 |
| 122 | Onion bulb formation (HP:0003383) | 1.69823781 |
| 123 | Pathologic fracture (HP:0002756) | 1.69535154 |
| 124 | Vascular calcification (HP:0004934) | 1.69274871 |
| 125 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.69254757 |
| 126 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.69254757 |
| 127 | Mitral regurgitation (HP:0001653) | 1.69113510 |
| 128 | Tetraparesis (HP:0002273) | 1.68663764 |
| 129 | Malnutrition (HP:0004395) | 1.67961997 |
| 130 | Epidermoid cyst (HP:0200040) | 1.67844606 |
| 131 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.67135914 |
| 132 | Abnormality of glycine metabolism (HP:0010895) | 1.67135914 |
| 133 | Beaking of vertebral bodies (HP:0004568) | 1.66804570 |
| 134 | Thoracic kyphosis (HP:0002942) | 1.66569248 |
| 135 | Gingivitis (HP:0000230) | 1.65592284 |
| 136 | Thin bony cortex (HP:0002753) | 1.65201411 |
| 137 | Prolonged neonatal jaundice (HP:0006579) | 1.64913572 |
| 138 | Dementia (HP:0000726) | 1.62209209 |
| 139 | Flat acetabular roof (HP:0003180) | 1.59663984 |
| 140 | Increased variability in muscle fiber diameter (HP:0003557) | 1.59152317 |
| 141 | Abnormality of the thoracic spine (HP:0100711) | 1.57714530 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.74136220 |
| 2 | IRAK3 | 3.65942689 |
| 3 | EPHB1 | 3.56923717 |
| 4 | ERN1 | 3.20610104 |
| 5 | STK39 | 2.90518567 |
| 6 | PRPF4B | 2.83765992 |
| 7 | WNK4 | 2.49549030 |
| 8 | MET | 2.45229121 |
| 9 | TTN | 2.36744116 |
| 10 | NME2 | 2.21303348 |
| 11 | OXSR1 | 2.06931194 |
| 12 | PKN2 | 1.89648364 |
| 13 | SCYL2 | 1.86072292 |
| 14 | TAOK2 | 1.85260669 |
| 15 | MAP3K14 | 1.81094196 |
| 16 | SIK1 | 1.81003503 |
| 17 | RIPK1 | 1.76660482 |
| 18 | DDR2 | 1.70816895 |
| 19 | NTRK1 | 1.70568155 |
| 20 | BMX | 1.68783776 |
| 21 | PTK6 | 1.67480293 |
| 22 | LATS2 | 1.62117308 |
| 23 | SMG1 | 1.59186205 |
| 24 | CAMK1D | 1.58546921 |
| 25 | PDGFRA | 1.56241535 |
| 26 | LRRK2 | 1.55834008 |
| 27 | CDC42BPA | 1.54830387 |
| 28 | BCKDK | 1.49611246 |
| 29 | KSR2 | 1.48317589 |
| 30 | GRK7 | 1.45074262 |
| 31 | PTK2 | 1.43147062 |
| 32 | MAP3K2 | 1.41770122 |
| 33 | MAP3K13 | 1.40424020 |
| 34 | PBK | 1.35612977 |
| 35 | MAP3K11 | 1.34673351 |
| 36 | WNK1 | 1.32498020 |
| 37 | ICK | 1.32211348 |
| 38 | EPHB2 | 1.29352209 |
| 39 | CAMK1G | 1.28350980 |
| 40 | TGFBR2 | 1.24586551 |
| 41 | TAOK1 | 1.22907212 |
| 42 | CDK12 | 1.20070345 |
| 43 | ARAF | 1.20043630 |
| 44 | FGFR4 | 1.19779884 |
| 45 | TBK1 | 1.18965569 |
| 46 | ZAP70 | 1.18051545 |
| 47 | PIM2 | 1.17420218 |
| 48 | LIMK1 | 1.16965368 |
| 49 | FGFR2 | 1.12035180 |
| 50 | PAK3 | 1.11271123 |
| 51 | MST1R | 1.07779404 |
| 52 | PAK4 | 1.07660861 |
| 53 | EEF2K | 1.07523344 |
| 54 | TESK1 | 1.05427322 |
| 55 | TAOK3 | 1.04803048 |
| 56 | TESK2 | 1.01400222 |
| 57 | RPS6KA2 | 1.00417826 |
| 58 | PAK2 | 0.95085963 |
| 59 | BLK | 0.93665980 |
| 60 | FGR | 0.93317666 |
| 61 | PDGFRB | 0.92107568 |
| 62 | PDPK1 | 0.91549649 |
| 63 | RET | 0.91330034 |
| 64 | IRAK4 | 0.90933642 |
| 65 | MAPK15 | 0.90784701 |
| 66 | PAK6 | 0.90146552 |
| 67 | MATK | 0.90033453 |
| 68 | LATS1 | 0.88097582 |
| 69 | PRKD1 | 0.87954980 |
| 70 | ABL2 | 0.85558032 |
| 71 | PRKD2 | 0.84619993 |
| 72 | GSK3A | 0.83043425 |
| 73 | MAP2K2 | 0.82322482 |
| 74 | JAK1 | 0.82217109 |
| 75 | JAK3 | 0.81613049 |
| 76 | TYK2 | 0.81300513 |
| 77 | NEK9 | 0.80645051 |
| 78 | MAP3K3 | 0.79956532 |
| 79 | PRKD3 | 0.79804066 |
| 80 | MOS | 0.78190665 |
| 81 | MAP3K6 | 0.75432949 |
| 82 | CSK | 0.74887128 |
| 83 | RIPK4 | 0.74698757 |
| 84 | PKN1 | 0.74437460 |
| 85 | ROCK2 | 0.74027982 |
| 86 | MAPKAPK5 | 0.73837709 |
| 87 | DYRK1B | 0.73705748 |
| 88 | FER | 0.72727277 |
| 89 | PRKG2 | 0.72718609 |
| 90 | MAP3K1 | 0.72203248 |
| 91 | DMPK | 0.71426595 |
| 92 | MYLK | 0.71287257 |
| 93 | EPHA3 | 0.69932081 |
| 94 | TRPM7 | 0.69710686 |
| 95 | RPS6KL1 | 0.69245735 |
| 96 | RPS6KC1 | 0.69245735 |
| 97 | ERBB4 | 0.68874626 |
| 98 | WNK3 | 0.67739771 |
| 99 | PDK2 | 0.67590217 |
| 100 | EPHA2 | 0.67580319 |
| 101 | INSRR | 0.67433946 |
| 102 | IRAK2 | 0.67400414 |
| 103 | STK10 | 0.66410952 |
| 104 | JAK2 | 0.66259759 |
| 105 | MARK2 | 0.64777886 |
| 106 | PRKCH | 0.64580270 |
| 107 | MTOR | 0.64101020 |
| 108 | TYRO3 | 0.63023636 |
| 109 | CAMKK2 | 0.62256260 |
| 110 | LMTK2 | 0.61111476 |
| 111 | EGFR | 0.61051524 |
| 112 | CSF1R | 0.57196986 |
| 113 | IKBKB | 0.55334582 |
| 114 | STK3 | 0.54847732 |
| 115 | CSNK1A1L | 0.54599468 |
| 116 | PDK3 | 0.54456967 |
| 117 | PDK4 | 0.54456967 |
| 118 | MAP2K1 | 0.54173627 |
| 119 | PIK3CG | 0.54148963 |
| 120 | MAPK7 | 0.53293994 |
| 121 | MAP2K3 | 0.51865828 |
| 122 | CAMKK1 | 0.51557142 |
| 123 | PTK2B | 0.50947730 |
| 124 | KIT | 0.48027986 |
| 125 | FGFR3 | 0.47031795 |
| 126 | RPS6KA6 | 0.45147898 |
| 127 | INSR | 0.44468043 |
| 128 | PHKG2 | 0.44265905 |
| 129 | PHKG1 | 0.44265905 |
| 130 | STK38 | 0.43146452 |
| 131 | CHUK | 0.42701181 |
| 132 | PDK1 | 0.41905611 |
| 133 | FYN | 0.40707940 |
| 134 | DAPK3 | 0.40207746 |
| 135 | CDK6 | 0.40020819 |
| 136 | MAP3K8 | 0.39930383 |
| 137 | HIPK2 | 0.39850696 |
| 138 | SRC | 0.39415569 |
| 139 | IKBKE | 0.36396554 |
| 140 | MAP4K1 | 0.35545927 |
| 141 | SGK3 | 0.35303086 |
| 142 | MAP3K9 | 0.34641891 |
| 143 | MAPK4 | 0.34436871 |
| 144 | MAPK12 | 0.33249113 |
| 145 | MAPKAPK2 | 0.32701488 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.54535852 |
| 2 | * Lysosome_Homo sapiens_hsa04142 | 2.80620264 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.52477977 |
| 4 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.40807100 |
| 5 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.23854791 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.09832592 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.89191822 |
| 8 | Other glycan degradation_Homo sapiens_hsa00511 | 1.88579307 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.83499785 |
| 10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.83455093 |
| 11 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.75611358 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.74362870 |
| 13 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.70548954 |
| 14 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.68370426 |
| 15 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.68246140 |
| 16 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.68138768 |
| 17 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.60878182 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.58504915 |
| 19 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.55659221 |
| 20 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.53628148 |
| 21 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.52220397 |
| 22 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.43707607 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.41195832 |
| 24 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.39744605 |
| 25 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.38575066 |
| 26 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.36790217 |
| 27 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.36289540 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.34194649 |
| 29 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.33988361 |
| 30 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.33248137 |
| 31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.32788459 |
| 32 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.30771793 |
| 33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.24688330 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.23259250 |
| 35 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.20529663 |
| 36 | Peroxisome_Homo sapiens_hsa04146 | 1.20141807 |
| 37 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.17161066 |
| 38 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.11040140 |
| 39 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.10527633 |
| 40 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.08972881 |
| 41 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.03957999 |
| 42 | Galactose metabolism_Homo sapiens_hsa00052 | 1.02513635 |
| 43 | * Phagosome_Homo sapiens_hsa04145 | 1.01163207 |
| 44 | Hepatitis C_Homo sapiens_hsa05160 | 0.99273070 |
| 45 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.98830699 |
| 46 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.98821253 |
| 47 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.96973802 |
| 48 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.96542598 |
| 49 | Shigellosis_Homo sapiens_hsa05131 | 0.96381793 |
| 50 | Prion diseases_Homo sapiens_hsa05020 | 0.95920886 |
| 51 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.94074428 |
| 52 | Influenza A_Homo sapiens_hsa05164 | 0.92247386 |
| 53 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.91838423 |
| 54 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.91150726 |
| 55 | Mineral absorption_Homo sapiens_hsa04978 | 0.91071226 |
| 56 | Legionellosis_Homo sapiens_hsa05134 | 0.90093335 |
| 57 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.89730141 |
| 58 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.89456986 |
| 59 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.89392164 |
| 60 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.89256624 |
| 61 | Amoebiasis_Homo sapiens_hsa05146 | 0.87715975 |
| 62 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.87320723 |
| 63 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.87159538 |
| 64 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.86897714 |
| 65 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.86297589 |
| 66 | Apoptosis_Homo sapiens_hsa04210 | 0.85455828 |
| 67 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.85380578 |
| 68 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.83892013 |
| 69 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.83436825 |
| 70 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.83147885 |
| 71 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.82903189 |
| 72 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.82224239 |
| 73 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.81646930 |
| 74 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.80226992 |
| 75 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.80218098 |
| 76 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.79731908 |
| 77 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.77837358 |
| 78 | Hepatitis B_Homo sapiens_hsa05161 | 0.77426677 |
| 79 | Carbon metabolism_Homo sapiens_hsa01200 | 0.75138816 |
| 80 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.75120400 |
| 81 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.73703707 |
| 82 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.73608874 |
| 83 | Focal adhesion_Homo sapiens_hsa04510 | 0.73167929 |
| 84 | ABC transporters_Homo sapiens_hsa02010 | 0.73025296 |
| 85 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.72964477 |
| 86 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.72893882 |
| 87 | Malaria_Homo sapiens_hsa05144 | 0.72378755 |
| 88 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.71316139 |
| 89 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.71156701 |
| 90 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.70847004 |
| 91 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.69444769 |
| 92 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.69215762 |
| 93 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.69131510 |
| 94 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.68569663 |
| 95 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.67347187 |
| 96 | Endocytosis_Homo sapiens_hsa04144 | 0.67029635 |
| 97 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.66877509 |
| 98 | Viral myocarditis_Homo sapiens_hsa05416 | 0.66217557 |
| 99 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.66179943 |
| 100 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.65614465 |
| 101 | Allograft rejection_Homo sapiens_hsa05330 | 0.65527511 |
| 102 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.65418852 |
| 103 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.65295256 |
| 104 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.65147359 |
| 105 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.65078138 |
| 106 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.64636605 |
| 107 | Pertussis_Homo sapiens_hsa05133 | 0.64470360 |
| 108 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.64454141 |
| 109 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.63711377 |
| 110 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.63544158 |
| 111 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.62457477 |
| 112 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.62004057 |
| 113 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.61979217 |
| 114 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.59484303 |
| 115 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.58008034 |
| 116 | Endometrial cancer_Homo sapiens_hsa05213 | 0.57394765 |
| 117 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.56371216 |
| 118 | Insulin resistance_Homo sapiens_hsa04931 | 0.56068177 |
| 119 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.53596683 |
| 120 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.53114348 |
| 121 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.53099454 |
| 122 | Measles_Homo sapiens_hsa05162 | 0.53047159 |
| 123 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52233631 |
| 124 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.52203813 |
| 125 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.52117748 |
| 126 | Platelet activation_Homo sapiens_hsa04611 | 0.51605797 |
| 127 | Glioma_Homo sapiens_hsa05214 | 0.51459078 |
| 128 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.50071954 |
| 129 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.49995914 |
| 130 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.49803002 |
| 131 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.49177113 |
| 132 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.49118370 |
| 133 | Asthma_Homo sapiens_hsa05310 | 0.49039426 |
| 134 | Adherens junction_Homo sapiens_hsa04520 | 0.48530638 |
| 135 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.48132788 |
| 136 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.46707008 |
| 137 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.46143218 |
| 138 | Bladder cancer_Homo sapiens_hsa05219 | 0.45999776 |
| 139 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.45551858 |
| 140 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.44942230 |
| 141 | * Tuberculosis_Homo sapiens_hsa05152 | 0.44377213 |
| 142 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44264317 |
| 143 | Prostate cancer_Homo sapiens_hsa05215 | 0.44168834 |
| 144 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.43905090 |
| 145 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.43851018 |
| 146 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.42771929 |
| 147 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.42334510 |
| 148 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.42116901 |
| 149 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.42027756 |
| 150 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.41775649 |
| 151 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.41562103 |
| 152 | Leishmaniasis_Homo sapiens_hsa05140 | 0.41230903 |
| 153 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.38992652 |
| 154 | Lysine degradation_Homo sapiens_hsa00310 | 0.36790652 |
| 155 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.36465362 |
| 156 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.35443914 |
| 157 | Salmonella infection_Homo sapiens_hsa05132 | 0.35146034 |

